Targeting the mTOR-DEPTOR Pathway by CRL E3 Ubiquitin Ligases: Therapeutic Application
The mammalian target of rapamycin (mTOR), an evolutionarily conserved serine/threonine protein kinase, integrates both intracellular and extracellular signals and serves as a central regulator of cell metabolism, growth, proliferation, survival, and autophagy. The mTOR pathway is frequently activat...
Main Authors: | Yongchao Zhao, Yi Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-05-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S147655861280011X |
Similar Items
-
Regulation of human mTOR complexes by DEPTOR
by: Matthias Wälchli, et al.
Published: (2021-09-01) -
Investigation of CRL2 ubiquitin ligase function
by: Hsiu-Chuan Lin, et al.
Published: (2019) -
CRL Ubiquitin Ligases and DNA Damage Response
by: Jianping eJin, et al.
Published: (2012-04-01) -
Insights into the regulation of the CRL4D̳T̳L̳ ubiquitin ligase
by: Lee, Crystal Jayne
Published: (2012) -
DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
by: Peterson, Timothy R., et al.
Published: (2015)